View Older Stories View More Recent Stories

Jan 13, 2026 07:27AM Travere Therapeutics (TVTX) Reiterated at Hold by Stifel After FDA Asks for More Info
Jan 13, 2026 04:57AM Stifel on Travere Therapeutics (TVTX): 'FSGS Increases Risk of CRL, Though Delay/Approval Still Possible'
Jan 12, 2026 05:00PM Travere reports record Q4 FILSPARI sales of $103 million
Dec 24, 2025 11:54AM FDA;s messaging is positive for Travere Therapeutics (TVTX) - Cantor Fitzgerald
Dec 23, 2025 05:30PM Jefferies lists 5 biotech M&A candidates for 2026
Oct 31, 2025 09:04AM Travere Therapeutics (TVTX) PT Raised to $48 at Citi, New Catalyst Watch
Oct 30, 2025 04:07PM Travere Therapeutics (TVTX) Tops Q3 EPS by 88c
Sep 26, 2025 07:02AM KDIGO guidelines include FILSPARI for IgA nephropathy treatment
Sep 22, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Travere Therapeutics (TVTX)
Sep 11, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Travere Therapeutics (TVTX)
Sep 10, 2025 11:01AM H.C. Wainwright on Travere Therapeutics (TVTX): 'We see adapted REMS as competitive advantage. We view this as positive news for Travere, particularly as it competes with Novartis’ (NVO; not rated)
Sep 10, 2025 10:30AM Jefferies on Travere Therapeutics (TVTX): 'AdCom Cancellation Clear Positive In Our View Setting Stage For Likely Approval'
Sep 10, 2025 10:11AM Stifel Reiterates Hold Rating on Travere Therapeutics (TVTX)
Sep 10, 2025 09:58AM Cantor Fitzgerald Comments on Travere Therapeutics (TVTX) Amid Shares Gaining 22pct
Sep 10, 2025 07:01AM FDA cancels advisory committee for Travere's FILSPARI in rare kidney disease
Sep 4, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Travere Therapeutics (TVTX)
Aug 28, 2025 07:33AM Travere Therapeutics (TVTX) PT Raised to $47 at H.C. Wainwright
Aug 7, 2025 10:06AM Travere Therapeutics (TVTX) PT Lowered to $20 at Stifel
Aug 6, 2025 04:03PM Travere Therapeutics (TVTX) Tops Q2 EPS by 16c
Jun 11, 2025 06:19AM H.C. Wainwright Assumes Travere Therapeutics (TVTX) at Buy
Jun 11, 2025 04:58AM Travere Therapeutics (TVTX) PT Lowered to $32 at Citi, Adds 90d Upside Catalyst Watch
May 19, 2025 03:38PM Travere Therapeutics (TVTX) call put ratio 1 call to 2.8 puts with a focus on June 15 and 17.50 puts
May 16, 2025 09:24AM Stifel Reiterates Hold Rating on Travere Therapeutics (TVTX)
May 16, 2025 06:37AM Cantor Fitzgerald Reiterates Overweight Rating on Travere Therapeutics (TVTX)
May 16, 2025 04:20AM Citi on Travere Therapeutics (TVTX): 'we would buy the dip', Opens 30-Day Upside Catalyst Call
May 15, 2025 04:22PM Travere Therapeutics (TVTX) Announces FDA Acceptance of sNDA for FILSPARI in FSGS
May 1, 2025 04:03PM Travere Therapeutics (TVTX) Tops Q1 EPS by 36c
Apr 29, 2025 07:07AM Travere Therapeutics (TVTX) and CSL Vifor Announce Standard EU Approval of FILSPARI (sparsentan) for IgA Nephropathy
Apr 28, 2025 07:19AM Cantor Fitzgerald Reiterates Overweight Rating on Travere Therapeutics (TVTX)
Apr 23, 2025 09:40AM Cantor Fitzgerald Reiterates Overweight Rating on Travere Therapeutics (TVTX)
Apr 10, 2025 06:28AM Travere Therapeutics (TVTX) PT Raised to $47 at Canaccord Genuity
Apr 3, 2025 07:18AM Cantor Fitzgerald Reiterates Overweight Rating on Travere Therapeutics (TVTX)
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Mar 31, 2025 04:31PM Travere Therapeutics (TVTX) to Present New FILSPARI Data at the National Kidney Foundation Spring Clinical Meetings 2025
Mar 17, 2025 07:01AM Travere Therapeutics (TVTX) Submits sNDA to FDA for Approval of FILSPARI
Feb 24, 2025 04:58AM Travere Therapeutics (TVTX) PT Raised to $35 at Citi
Feb 20, 2025 05:19PM Travere Therapeutics (TVTX) Tops Q4 EPS by 17c
Feb 12, 2025 07:10AM Travere Therapeutics (TVTX) PT Raised to $32 at Scotiabank
Feb 12, 2025 06:36AM Travere Therapeutics (TVTX) PT Raised to $45 at Canaccord Genuity
Jan 22, 2025 03:23PM Travere Therapeutics (TVTX) call put ratio 2.7 calls to 1 put with a focus on a spreader of March 20 and 30 calls
Nov 30, 2024 10:00PM JPMorgan is out with its 2025 outlook for biotech stocks
Nov 19, 2024 11:00AM JPM just added these stocks to its Analyst Focus List - giving one 148% upside
Nov 8, 2024 06:11AM Travere Therapeutics (TVTX) Prices 7.81M Share Offering at $16/sh
Nov 7, 2024 04:02PM Travere Therapeutics (TVTX) Announces Proposed Share Offering
Oct 31, 2024 04:21PM Travere Therapeutics (TVTX) PT Raised to $33 at Evercore ISI
Oct 29, 2024 10:11AM TD Cowen Reiterates Buy Rating on Travere Therapeutics (TVTX)
Oct 21, 2024 06:42AM Wells Fargo Upgrades Travere Therapeutics (TVTX) to Overweight
Oct 20, 2024 10:00AM 4 biotech stocks to own to benefit from key Q4 catalysts
Oct 17, 2024 07:01AM Travere Therapeutics (TVTX) and CSL Vifor Announce Swissmedic Approval of FILSPARI
Oct 10, 2024 05:26AM Wells Fargo Reiterates Equal Weight Rating on Travere Therapeutics (TVTX)
View More Recent Stories View Older Stories